Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: A hospital-based cross-sectional study

Journal of Community Health

Volumn 35, Issue 5, 2010, Pages 471-478

  Sardar, Partha ^a   Jha, Ayan ^b   Roy, Deeptarka ^a   Roy, Sabyasachi ^a   Guha, Pradipta ^a   Bandyopadhyay, Dipanjan ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

Author keywords

Adherence; Counseling; HIV TB coinfection; Intensive phase

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRE; REGRESSION ANALYSIS; STATISTICS; UNIVERSITY HOSPITAL;

ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 78650204067     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-009-9215-z     Document Type: Article

References (38)

1. Di Perri, G., Cruciani, M., Danzi, M. C., et al. (1989). Nosocomial epidemic of active tuberculosis among HIV infected patients. Lancet, 2, 1502-1504.
2. Selwyn, P. A., Hartel, D., Lewis, V. A., et al. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine, 320, 545-550.
3. Bell, J. C., Rose, D. N., & Sacks, H. S. (1999). Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS, 13(12), 1549-1556.
4. Lucas, S. B., Hounnou, A., Peacock, C., et al. (1993). The mortality and pathology of HIV infection in a west African city. AIDS, 7, 1569-1579.
5. World Health Organization. (2009). WHO Report 2009:Global tuberculosis control-epidemiology, strategy, financing. WHO report 2009. Geneva, World Health Organization, WHO/HTM/ TB/2009.411.
6. TB India. (2009). RNTCP Status Report. Central TB Division. March 2009.
7. Blöndal, K. (2007). Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ, 85(5), 387-390.
8. World Health Organization. (2001). The Global Plan to Stop TB. Geneva:World Health Organization; [WHO/CDS/STB/2001.16.
9. de Cock, K., & Chaisson, R. E. (1999). Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis, 3, 457-465.
10. Currie, C. S., Williams, B. G., Cheng, R. C., & Dye, C. (2003). Tuberculosis epidemics driven by HIV: Is prevention better than cure? AIDS, 17(17), 2501-2508.
11. Thiam, S., LeFevre, A. M., Hane, F., Ndiaye, A., Ba, F., Fielding, K. L., et al. (2007). Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting. JAMA, 297(4), 380-386.
12. Sumartojo, E. (1993). When tuberculosis treatment fails: a social behavorial account of patient adherence. Am Rev Respir Dis, 147, 1311-1320.
13. Menzies, R., Rocher, I., & Vissandjee, B. (1993). Factors associated with compliance in treatment of tuberculosis. Tubercle and Lung Disease, 74, 32-37.
14. Tadios, Y., & Davey, G. (2006). Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiopian Medical Journal, 44(3), 237-244.
15. Battaglioli-DeNero, A. M. (2007). Strategies for improving patient adherence to therapy and long term patient outcomes. J Assoc Nurses AIDS Care, 18(1), 17-22.
16. Brook, M. G., Dale, A., Tomlinson, D., Waterworth, C., Daniels, D., & Forster, G. (2001). Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units. AIDS Patient Care STDS, 15(9), 491-494.
17. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care STDS, 17(4), 169-177.
18. Kaona, F. A., Tuba, M., Siziya, S., & Sikaona, L. (2004). An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health, 4, 68.
19. Bam, T. S., Gunneberg, C., Chamroonsawasdi, K., Bam, D. S., Aalberg, O., Kasland, O., et al. (2006). Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis, 10(3), 270-276.
20. Park, K. (2009). Park's textbook of preventive and social medicine (20th ed., p. 596). Jabalpur: M/s Banarsidas Bhanot Publishers.
21. Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007). Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med, 4(7), e238.
22. WHO. (2003). Adherence to long term therapies: Evidence for action. Geneva: World Health Organization. Available at: http://www.who.int/chp/ knowledge/publications/adherence-full-report.pdf. Accessed: 6 February 2006.
23. Vermeire, E., Hearnshaw, H., van Royen, P., & Denekens, J. (2001). Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharmacol Ther, 26, 331-342.
24. Kapella, B. K., Anuwatnonthakate, A., Komsakorn, S., Moolphate, S., Charusuntonsri, P., Limsomboon, P., et al. (2009). Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand. Int J Tuberc Lung Dis, 13(2), 232-237.
25. Swaminathan, S., & Narendran, G. (2008). HIV and tuberculosis in India. Journal of Biosciences, 33(4), 527-537.
26. Volmink, J., & Garner, P. (2007). Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev, 4, CD003343.
27. Khan, A., Walley, J., Newell, J., & Imdad, N. (2000). Tuberculosis in Pakistan: Socio cultural constraints and opportunities in treatment. Social Science and Medicine, 50, 247-254.
28. Jaiswal, A., Singh, V., Ogden, J. A., Porter, J. D., Sharma, P. P., et al. (2003). Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Tropical Medicine and International Health, 8, 625-633.
29. Johansson, E., Long, N. H., Diwan, V. K., & Winkvist, A. (1999). Attitudes to compliance with tuberculosis treatment among women and men in Vietnam. Int J Tuberc Lung Dis, 3, 862-868.
30. San Sebastian, M., & Bothamley, G. H. (2000). Tuberculosis preventive therapy: Perspective from a multi-ethnic community. Respiratory Medicine, 94, 648-653.
31. Marra, C. A., Marra, F., Cox, V. C., Palepu, A., & Fitzgerald, J. M. (2004). Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes, 2, 58-68.
32. Mata, J. I. (1985). Integrating the client perspective in planning a tuberculosis education and treatment program in Honduras. Medical Anthropology, 9, 57-64.
33. Liefooghe, R., Michiels, N., Habib, S., Moran, M. B., & de Muynck, A. (1995). Perception and social consequences of tuberculosis: A focus group study of tuberculosis patients in Sialkot, Pakistan. Social Science and Medicine, 41, 1685-1692.
34. Greene, J. A. (2004). An ethnography of non-adherence: Culture, poverty, and tuberculosis in urban Bolivia. Culture, Medicine and Psychiatry, 28, 401-425.
35. Edginton, M. E., & Sekatane, C. S. (2002). Goldstein SJ Patients' beliefs: Do they affect tuberculosis control? A study in a rural district of South Africa. Int J Tuberc Lung Dis, 6, 1075-1082.
36. Rowe, K. A., Makhubele, B., Hargreaves, J. R., Porter, J. D., Hausler, H. P., et al. (2005). Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: Implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis, 9, 263-269.
37. Sánchez, M. S., Lloyd-Smith, J. O., Porco, T. C., Williams, B. G., Borgdorff, M. W., Mansoer, J., et al. (2008). Impact of HIV on novel therapies for tuberculosis control. AIDS, 22(8), 963-972.
38. Mwinga, A. (2009). Low-income countries: where are we going with TB-HIV in 2009? Int J Tuberc Lung Dis, 13(7), 797-798.